Role of wireless motility capsule in the assessment and management of gastrointestinal dysmotility in patients with diabetes mellitus.

Carol RouphaelZ AroraP N ThotaR LopezJ SantisiC FunkM Cline

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2017)

There was no association between hemoglobinA1c levels, microvascular complications and pattern of GI dysmotility in diabetic patients undergoing WMC. WMC testing lead to management changes in approximately 75% of diabetic patients with GI dysmotility.

Keyphrases

patients undergoing
type diabetes
wound healing
risk factors
adipose tissue
skeletal muscle
glycemic control